BACKGROUND: Circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin have been associated with variation at the ABO locus. To evaluate these associations and the effect sizes, we performed a meta-analysis with new and previous reported data for polymorphism rs579459. METHODS AND RESULTS: Compared with major allele homozygotes, heterozygotes and minor allele homozygotes had 4.6% (95% CI, 3.4%-5.8%, P=7.3 × 10(-14)) and 7.2% (95% CI, 4.7%-9.7%, P=1.5 × 10(-8)), respectively, lower soluble intercellular adhesion molecule-1 levels (n=33 671). An allele dose-dependent association also was observed for soluble P-selectin (n=4921) with heterozygotes and minor allele homozygotes having 11.5% (95% CI, 7.2%-15.8%, P=1.7 × 10(-7)) and 18.6% (95% CI, 9.1%-28.1%, P=1.2 × 10(-4)), respectively, lower levels than in major allele homozygotes. A larger effect size, again consistent with an additive genetic model, was seen for soluble E-selectin (n=2860) whose level was 25.6% (95% CI, 19.0%-32.2%, P=2.1 × 10(-14)) lower in heterozygotes and 43.3% (95% CI, 36.9%-49.3%, P=4.3 × 10(-42)) lower in minor allele homozygotes than in major allele homozygotes. CONCLUSIONS: The data support the association of variation at the ABO locus with soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin levels.
BACKGROUND: Circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin have been associated with variation at the ABO locus. To evaluate these associations and the effect sizes, we performed a meta-analysis with new and previous reported data for polymorphism rs579459. METHODS AND RESULTS: Compared with major allele homozygotes, heterozygotes and minor allele homozygotes had 4.6% (95% CI, 3.4%-5.8%, P=7.3 × 10(-14)) and 7.2% (95% CI, 4.7%-9.7%, P=1.5 × 10(-8)), respectively, lower soluble intercellular adhesion molecule-1 levels (n=33 671). An allele dose-dependent association also was observed for soluble P-selectin (n=4921) with heterozygotes and minor allele homozygotes having 11.5% (95% CI, 7.2%-15.8%, P=1.7 × 10(-7)) and 18.6% (95% CI, 9.1%-28.1%, P=1.2 × 10(-4)), respectively, lower levels than in major allele homozygotes. A larger effect size, again consistent with an additive genetic model, was seen for soluble E-selectin (n=2860) whose level was 25.6% (95% CI, 19.0%-32.2%, P=2.1 × 10(-14)) lower in heterozygotes and 43.3% (95% CI, 36.9%-49.3%, P=4.3 × 10(-42)) lower in minor allele homozygotes than in major allele homozygotes. CONCLUSIONS: The data support the association of variation at the ABO locus with soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin levels.
Authors: Miryoung Lee; Stefan A Czerwinski; Audrey C Choh; Ellen W Demerath; Shumei S Sun; Wm C Chumlea; Bradford Towne; Roger M Siervogel Journal: Atherosclerosis Date: 2005-07-07 Impact factor: 5.162
Authors: S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle Journal: Circulation Date: 1997-12-16 Impact factor: 29.690
Authors: Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz Journal: N Engl J Med Date: 2002-07-18 Impact factor: 91.245
Authors: John P Reilly; Nuala J Meyer; Michael G S Shashaty; Rui Feng; Paul N Lanken; Robert Gallop; Sandra Kaplan; Maximilian Herlim; Nathaniel L Oz; Isabel Hiciano; Ana Campbell; Daniel N Holena; Muredach P Reilly; Jason D Christie Journal: Chest Date: 2014-04 Impact factor: 9.410
Authors: Wolfgang Lieb; Ming-Huei Chen; Martin G Larson; Radwan Safa; Alexander Teumer; Sebastian E Baumeister; Honghuang Lin; Holly M Smith; Manja Koch; Roberto Lorbeer; Uwe Völker; Matthias Nauck; Henry Völzke; Henri Wallaschofski; Douglas B Sawyer; Ramachandran S Vasan Journal: Circ Cardiovasc Genet Date: 2014-12-31
Authors: John P Reilly; Nuala J Meyer; Michael Gs Shashaty; Brian J Anderson; Caroline Ittner; Thomas G Dunn; Brian Lim; Caitlin Forker; Michael P Bonk; Ethan Kotloff; Rui Feng; Edward Cantu; Nilam S Mangalmurti; Carolyn S Calfee; Michael A Matthay; Carmen Mikacenic; Keith R Walley; James Russell; David C Christiani; Mark M Wurfel; Paul N Lanken; Muredach P Reilly; Jason D Christie Journal: J Clin Invest Date: 2021-01-04 Impact factor: 14.808
Authors: Nicholas B Larson; Elizabeth J Bell; Paul A Decker; Mindy Pike; Christina L Wassel; Michael Y Tsai; James S Pankow; Weihong Tang; Naomi Q Hanson; Kristine Alexander; Neil A Zakai; Mary Cushman; Suzette J Bielinski Journal: Atherosclerosis Date: 2016-06-07 Impact factor: 5.162
Authors: Nicholas B Larson; Paul A Decker; Christina L Wassel; James S Pankow; Weihong Tang; Naomi Q Hanson; Michael Y Tsai; Suzette J Bielinski Journal: Hum Genet Date: 2016-02-16 Impact factor: 4.132
Authors: John P Reilly; Brian J Anderson; Nilam S Mangalmurti; Tam D Nguyen; Daniel N Holena; Qufei Wu; Ethan T Nguyen; Muredach P Reilly; Paul N Lanken; Jason D Christie; Nuala J Meyer; Michael G S Shashaty Journal: Clin J Am Soc Nephrol Date: 2015-09-04 Impact factor: 8.237
Authors: Linda M Polfus; Laura M Raffield; Marsha M Wheeler; Russell P Tracy; Leslie A Lange; Guillaume Lettre; Amanda Miller; Adolfo Correa; Russell P Bowler; Joshua C Bis; Shabnam Salimi; Nancy Swords Jenny; Nathan Pankratz; Biqi Wang; Michael H Preuss; Lisheng Zhou; Arden Moscati; Girish N Nadkarni; Ruth J F Loos; Xue Zhong; Bingshan Li; Jill M Johnsen; Deborah A Nickerson; Alex P Reiner; Paul L Auer Journal: Hum Mol Genet Date: 2019-02-01 Impact factor: 6.150